Abstract:
Introduction: Bibliographic analysis of data confirms that incidence of tumor of pelvic bones is
on the increase and remains a difficult and current oncology. The epidemiological survey, clinical and
morphological research and surgical treatment of tumors of pelvic bones increases the vigilance.
Materials and Methods: To realize the purpose were subjected retrospective review the medical
records of 53 patients treated in Oncology Institute in the department Musculoskeletal tumors and tissues
tumors during 2011-2015. All patients were treated surgically. Postoperative material was taken for
histological examination.
Discussion results: The most tumors pelvic bones tumors group were assessed as malignant
(45.28%), the first being chondrosarcoma, (35.84%) are benign and (18.86%) pseudotumoral injuries.
From the benign tumors chondroma is on first place, and from the pseudotumors prevails processes
fibrous dysplasia of the coccygienne vertebrae. Report men:women in the group of patients with bone
tumors of the pelvis is 1.4:1. In most cases affected was the age between 40-60 years. Depending on the
location of the tumor process more frequently affects the body and the right wing of iliac bone, pubic
bone and vertebrae coccygea. Ischial bone is rarely involved. In patients with benign tumors and
pseudotumoral lesions commonly was biopsied and marginal resection of iliac bone. In 7 cases after
removing tumors pelvic bones were used preserved allografts for substitution of the defect.
Conclusion: Between malignant tumors of pelvic bones the highest incidence has primary
chondrosarcoma and metastasis without primary outbreak found. In most cases the neoplastic process
involving pelvic bone and vertebrae as coccygienne. The pubic bone and bone sciatic are affected in
unique cases. The surgery for tumors of the pelvis bone involve defect filling with allograft preserved.
It is necessary to implement new methods of treatment with a view to improve the quality of treatment
in tumors of the pelvic bones.
Description:
Oncology Department, Faculty of Medicine N1, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016